1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow Ge Zheng: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Azacytidine Combined With Lenalidomide As Maintenance Therapy Based on MRD Monitoring in AML Azacitidine, Lenalidomide - Acute Myeloid Leukemia in Remission | Phase 3 | Unknown | Ge Zheng | 60 | 2020-09-01 | 2022-03-24 |
Azacitidine (1) · Lenalidomide (1)
China (1)